Search results
Novavax (NVAX) Ascends While Market Falls: Some Facts to Note
Zacks via Yahoo Finance· 2 days agoNovavax (NVAX) closed the most recent trading day at $14.06, moving +1.99% from the previous trading...
Insider Sale: Director James Young Sells Shares of Novavax Inc (
Guru Focus· 5 days agoOn June 18, 2024, James Young, Director at Novavax Inc (NVAX, Financial), executed a sale of 7,500 shares of the company. The transaction was filed on the same day through ...
COVID-19 is surging. Time to mask up or get a booster? What a Boise medical expert says
Idaho Statesman McClatchy via AOL· 2 days agoBooster shots improve immunity Pate urges people to stay up to date with COVID-19 vaccines. The...
Novavax applies for FDA nod for its updated COVID vaccine
Center for Infectious Disease Research and Policy· 5 days agoThe company said it will have the vaccine ready to distribute in mid July as prefilled syringes, pending approval and recommendations.
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 2 days agoThe company noted that it achieved 48% market share for Covid vaccines in the U.S. during the fall...
Jim Cramer Says He's 'Going To Have To Wait' On SoFi, But Recommends This 'Great Little Industrial...
Benzinga· 6 days agoOn CNBC's “Mad Money Lightning Round,” Jim Cramer said he still can't recommend Twilio TWLO. On June...
Why 93% Of This Biotech's Value Just Went Up In Smoke
Investor's Business Daily· 5 days agoWedbush analyst Laura Chico slashed her price target on Aerovate stock to 3 from 41, calling the...
We Won't Solve Long COVID Until We Decide What It Is
Medscape· 5 days agoIs a slow recovery from COVID-19 the lingering effects of a bad infection or the start of a new syndrome?
Texas Biomed expanding animal research complex with $20 million building
San Antonio Express-News· 3 days agoThe 18,440-square-foot building will house Texas Biomed’s Animal Health Center, the next phase of...
Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?
Investor's Business Daily· 2 days agoThough it has a booster Covid shot, like rivals Moderna and Novavax, analysts don't expect sales to...